Mostrar el registro sencillo del ítem

dc.contributor.authorGarcía-Escobar, I.
dc.contributor.authorBrozos Vázquez, Elena María 
dc.contributor.authorGutierrez Abad, D.
dc.contributor.authorMartínez-Marín, V.
dc.contributor.authorPachón, V.
dc.contributor.authorMuñoz Martín, A. J.
dc.contributor.otherCancer and Thrombosis Section of the Spanish Society of Medical Oncology (SEOM)
dc.date.accessioned2024-01-02T10:04:59Z
dc.date.available2024-01-02T10:04:59Z
dc.date.issued2021
dc.identifier.issn1699-048X
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/33206333es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/18529
dc.description.abstractVenous thromboembolic disease (VTED) is a common and clinically important complication in patients with cancer, contributing to its mortality and morbidity. Direct oral anticoagulant agents (DOACs), including direct thrombin inhibitors and direct factor Xa inhibitors, are as effective as vitamin K antagonists for the treatment of VTED and are associated with less frequent and severe bleeding. They have advantages over low-molecular-weight heparin, but comparative long-term efficacy and safety data are lacking for these compounds. Recent randomized clinical trials suggest a role for DOACs in the treatment of VTED in patients with cancer. This review will discuss the existing evidence and future perspectives on the role of DOACs in the treatment of VTE based on the current evidence about their overall efficacy and safety and the limited information in patients with cancer; in addition, we will briefly review their pharmacokinetic properties with special reference to potential interactions.
dc.language.isoen
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleDirect oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
dc.typeJournal Articlees
dc.authorsophosGarcía-Escobar, I.;Brozos-Vázquez, E.;Gutierrez Abad, D.;Martínez-Marín, V.;Pachón, V.;Muñoz Martín, A. J.;(SEOM), Cancer and Thrombosis Section of the Spanish Society of Medical Oncology
dc.identifier.doi10.1007/s12094-020-02506-4
dc.identifier.pmid33206333
dc.identifier.sophos43950
dc.issue.number6
dc.journal.titleClinical & Translational Oncology
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.)::Área Sanitaria de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Oncoloxía médica
dc.page.initial1034
dc.page.final1046
dc.rights.accessRightsopenAccess
dc.subject.keywordÁrea Sanitaria de Santiago de Compostela e Barbanzaes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo de Revisiónes
dc.volume.number23


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional